You have searched for "CGS-CIMB"
Showing 11-20 of 831
CGS-CIMB Research, while keeping its earnings forecast for unchanged, has upgraded its call for Duopharma Biotech from a “hold’’ to an “add.’’
CGS-CIMB Equities Research has upgraded its recommendation for Duopharma Biotech to an add from hold and kept its target price at RM3.67, which is 25.2% above the last closing price of RM2.93.
BANK Negara’s overnight policy rate (OPR) will take centre stage. The central bank is expected to announce its monetary policy decision on Thursday and its international reserves as at April 30 on Friday.
PUBLIC-listed companies are discouraged from appointing active politicians, such as Members of Parliament and state assemblymen to their board of directors, the Securities Commission (SC) said in its latest update on the Malaysian Code of Corporate Governance (MCCG) released on Wednesday.
PETALING JAYA: After a slowdown in April, Asian polymer prices are expected to peak in the second quarter (Q2), which will determine the outcome and direction of the petrochemical sector.
GLOVE maker Kossan Rubber Industries Bhd made a net profit of RM1.01bil in the first quarter ended March 31, its best quarterly results so far, backed by higher sales volume and surging prices.
Company to prioritise on product mix, store expansion